The anti-oxidant and pro-oxidant dichotomy of Bcl-2

References

Armstrong, J.S. and Jones, D.P. (2002). Glutathione depletion enforces the mitochondrial permeability transition and causes cell death in Bcl-2 overexpressing HL60 cells. FASEB J. 16, 1263–1265.10.1096/fj.02-0097fjeSearch in Google Scholar

Ashkenazi, A. and Dixit, V.M. (1999). Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11, 255–260.10.1016/S0955-0674(99)80034-9Search in Google Scholar

Bakhshi, A., Jensen, J.P., Goldman, P., Wright, J.J., McBride, O.W., Epstein, A.L., and Korsmeyer, S.J. (1985). Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41, 899–906.10.1016/S0092-8674(85)80070-2Search in Google Scholar

Beenken, S.W., Grizzle, W.E., Crowe, D.R., Conner, M.G., Weiss, H.L., Sellers, M.T., Krontiras, H., Urist, M.M., and Bland, K.I. (2001). Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53. Ann. Surg. 233, 630–638.10.1097/00000658-200105000-00006Search in Google Scholar

Bender, T. and Martinou, J.C. (2013). Where killers meet – permeabilization of the outer mitochondrial membrane during apoptosis. Cold Spring Harbor Perspect. Biol. 5, a011106.10.1101/cshperspect.a011106Search in Google Scholar

Berndtsson, M., Hagg, M., Panaretakis, T., Havelka, A.M., Shoshan, M.C., and Linder, S. (2007). Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA. Int. J. Cancer 120, 175–180.10.1002/ijc.22132Search in Google Scholar

Bold, R.J., Virudachalam, S., and McConkey, D.J. (2001). BCL2 expression correlates with metastatic potential in pancreatic cancer cell lines. Cancer 92, 1122–1129.10.1002/1097-0142(20010901)92:5<1122::AID-CNCR1429>3.0.CO;2-HSearch in Google Scholar

Braun, F., de Carné Trécesson, S., Bertin-Ciftci, J., and Juin, P. (2013). Protect and serve: Bcl-2 proteins as guardians and rulers of cancer cell survival. Cell Cycle (Georgetown, TX) 12, 2937–2947.10.4161/cc.25972Search in Google Scholar

Cao, D.X., Qiao, B., Ge, Z.Q., and Yuan, Y.J. (2004). Comparison of burst of reactive oxygen species and activation of caspase-3 in apoptosis of K562 and HL-60 cells induced by docetaxel. Cancer Lett. 214, 103–113.10.1016/j.canlet.2004.03.047Search in Google Scholar

Charo, J., Finkelstein, S.E., Grewal, N., Restifo, N.P., Robbins, P.F., and Rosenberg, S.A. (2005). Bcl-2 overexpression enhances tumor-specific T-cell survival. Cancer Res. 65, 2001–2008.10.1158/0008-5472.CAN-04-2006Search in Google Scholar

Chen, Z.X. and Pervaiz, S. (2007). Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells. Cell Death Differ. 14, 1617–1627.10.1038/sj.cdd.4402165Search in Google Scholar

Chen, Z.X. and Pervaiz, S. (2010). Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2. Cell Death Differ. 17, 408–420.10.1038/cdd.2009.132Search in Google Scholar

Cleary, M.L., Smith, S.D., and Sklar, J. (1986). Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47, 19–28.10.1016/0092-8674(86)90362-4Search in Google Scholar

Clement, M.V., Hirpara, J.L., and Pervaiz, S. (2003). Decrease in intracellular superoxide sensitizes Bcl-2-overexpressing tumor cells to receptor and drug-induced apoptosis independent of the mitochondria. Cell Death Differ. 10, 1273–1285.10.1038/sj.cdd.4401302Search in Google Scholar PubMed

Deng, X., Ruvolo, P., Carr, B., and May, W.S., Jr. (2000). Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases. Proc. Nat. Acad. Sci. USA 97, 1578–1583.10.1073/pnas.97.4.1578Search in Google Scholar PubMed PubMed Central

Deng, X., Gao, F., and May, W.S., Jr. (2003). Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS. Blood 102, 3179–3185.10.1182/blood-2003-04-1027Search in Google Scholar PubMed

Ding, J., Zhang, Z., Roberts, G.J., Falcone, M., Miao, Y., Shao, Y., Zhang, X.C., Andrews, D.W., and Lin, J. (2010). Bcl-2 and Bax interact via the BH1-3 groove-BH3 motif interface and a novel interface involving the BH4 motif. J. Biol. Chem. 285, 28749–28763.10.1074/jbc.M110.148361Search in Google Scholar PubMed PubMed Central

Dlugosz, P.J., Billen, L.P., Annis, M.G., Zhu, W., Zhang, Z., Lin, J., Leber, B., and Andrews, D.W. (2006). Bcl-2 changes conformation to inhibit Bax oligomerization. EMBO J. 25, 2287–2296.10.1038/sj.emboj.7601126Search in Google Scholar PubMed PubMed Central

Ellerby, L.M., Ellerby, H.M., Park, S.M., Holleran, A.L., Murphy, A.N., Fiskum, G., Kane, D.J., Testa, M.P., Kayalar, C., and Bredesen, D.E. (1996). Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2. J. Neurochem. 67, 1259–1267.10.1046/j.1471-4159.1996.67031259.xSearch in Google Scholar PubMed

Erwig, L.P. and Henson, P.M. (2008). Clearance of apoptotic cells by phagocytes. Cell Death Differ. 15, 243–250.10.1038/sj.cdd.4402184Search in Google Scholar PubMed

Esposti, M.D., Hatzinisiriou, I., McLennan, H., and Ralph, S. (1999). Bcl-2 and mitochondrial oxygen radicals. New approaches with reactive oxygen species-sensitive probes. J. Biol. Chem. 274, 29831–29837.10.1074/jbc.274.42.29831Search in Google Scholar PubMed

Fennell, D.A. (2003). Bcl-2 as a target for overcoming chemoresistance in small-cell lung cancer. Clin. Lung Cancer 4, 307–313.10.3816/CLC.2003.n.012Search in Google Scholar PubMed

Frank, D.A. (2007). STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett. 251, 199–210.10.1016/j.canlet.2006.10.017Search in Google Scholar PubMed

Fulda, S. and Debatin, K.M. (2006). Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25, 4798–4811.10.1038/sj.onc.1209608Search in Google Scholar PubMed

Gao, P., Bauvy, C., Souquère, S., Tonelli, G., Liu, L., Zhu, Y., Qiao, Z., Bakula, D., Proikas-Cezanne, T., Pierron, G., et al. (2010). The Bcl-2 homology domain 3 mimetic gossypol induces both Beclin 1-dependent and Beclin 1-independent cytoprotective autophagy in cancer cells. J. Biol. Chem. 285, 25570–25581.10.1074/jbc.M110.118125Search in Google Scholar PubMed PubMed Central

Germain, D. and Frank, D.A. (2007). Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Clin. Cancer Res. 13, 5665–5669.10.1158/1078-0432.CCR-06-2491Search in Google Scholar PubMed

Green, D.R. (2005). Apoptotic pathways: ten minutes to dead. Cell 121, 671–674.10.1016/j.cell.2005.05.019Search in Google Scholar PubMed

Han, Z., Feng, J., Hong, Z., Chen, L., Li, W., Liao, S., Wang, X., Ji, T., Wang, S., Ma, D., et al. (2013). Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells. Biochem. Biophys. Res. Commun. 435, 188–194.10.1016/j.bbrc.2013.04.087Search in Google Scholar PubMed

Hanahan, D. and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57–70.10.1093/med/9780199656103.003.0001Search in Google Scholar

Hochman, A., Sternin, H., Gorodin, S., Korsmeyer, S., Ziv, I., Melamed, E., and Offen, D. (1998). Enhanced oxidative stress and altered antioxidants in brains of Bcl-2-deficient mice. J. Neurochem. 71, 741–748.10.1046/j.1471-4159.1998.71020741.xSearch in Google Scholar PubMed

Hockenbery, D.M., Oltvai, Z.N., Yin, X.M., Milliman, C.L., and Korsmeyer, S.J. (1993). Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241–251.10.1016/0092-8674(93)80066-NSearch in Google Scholar

Huang, L.-h., Hu, J.-q., Tao, W.-q., Li, Y.-h., Li, G.-m., Xie, P.-y., Liu, X.-s., and Jiang, J. (2010). Gossypol inhibits phosphorylation of Bcl-2 in human leukemia HL-60 cells. Eur. J. Pharmacol. 645, 9–13.10.1016/j.ejphar.2010.06.070Search in Google Scholar PubMed

Ito, T., Deng, X., Carr, B., and May, W.S. (1997). Bcl-2 phosphorylation required for anti-apoptosis function. J. Biol. Chem. 272, 11671–11673.10.1074/jbc.272.18.11671Search in Google Scholar PubMed

Jing, N. and Tweardy, D.J. (2005). Targeting Stat3 in cancer therapy. Anti-Cancer Drugs 16, 601–607.10.1097/00001813-200507000-00002Search in Google Scholar PubMed

Johnston, P.A. and Grandis, J.R. (2011). STAT3 signaling: anticancer strategies and challenges. Mol. Interventions 11, 18–26.10.1124/mi.11.1.4Search in Google Scholar PubMed PubMed Central

Juin, P., Geneste, O., Gautier, F., Depil, S., and Campone, M. (2013). Decoding and unlocking the BCL-2 dependency of cancer cells. Nat. Rev. Cancer 13, 455–465.10.1038/nrc3538Search in Google Scholar PubMed

Kang, J., Chong, S.J., Ooi, V.Z., Vali, S., Kumar, A., Kapoor, S., Abbasi, T., Hirpara, J.L., Loh, T., Goh, B.C., et al. (2015). Overexpression of Bcl-2 induces STAT-3 activation via an increase in mitochondrial superoxide. Oncotarget 6, 34191–34205.10.18632/oncotarget.5763Search in Google Scholar PubMed PubMed Central

Kerr, J.F.R., Wyllie, A.H., and Currie, A.R. (1972). Apoptosis: a basic biological phenomenon with wideranging implications in tissue kinetics. Brit. J. Cancer 26, 239–257.10.1038/bjc.1972.33Search in Google Scholar PubMed PubMed Central

Kim, Y.H. and Kim, S.S. (1999). Increase of MnSOD expression and decrease of JNK activity determine the TNF sensitivity in bcl2-transfected L929 cells. Cytokine 11, 274–281.10.1006/cyto.1998.0414Search in Google Scholar PubMed

Kirkland, R.A., Windelborn, J.A., Kasprzak, J.M., and Franklin, J.L. (2002). A Bax-induced pro-oxidant state is critical for cytochrome c release during programmed neuronal death. J. Neurosci. 22, 6480–6490.10.1523/JNEUROSCI.22-15-06480.2002Search in Google Scholar

Kirkland, R.A., Saavedra, G.M., Cummings, B.S., and Franklin, J.L. (2010). Bax regulates production of superoxide in both apoptotic and nonapoptotic neurons: role of caspases. J. Neurosci. 30, 16114–16127.10.1523/JNEUROSCI.2862-10.2010Search in Google Scholar PubMed PubMed Central

Kitada, S., Pedersen, I.M., Schimmer, A.D., and Reed, J.C. (2002). Dysregulation of apoptosis genes in hematopoietic malignancies. Oncogene 21, 3459–3474.10.1038/sj.onc.1205327Search in Google Scholar PubMed

Kowaltowski, A.J., Cosso, R.G., Campos, C.B., and Fiskum, G. (2002). Effect of Bcl-2 overexpression on mitochondrial structure and function. J. Biol. Chem. 277, 42802–42807.10.1074/jbc.M207765200Search in Google Scholar PubMed

Kowaltowski, A.J., Fenton, R.G., and Fiskum, G. (2004). Bcl-2 family proteins regulate mitochondrial reactive oxygen production and protect against oxidative stress. Free Radical Biol. Med. 37, 1845–1853.10.1016/j.freeradbiomed.2004.09.005Search in Google Scholar PubMed

Kowaltowski, A.J. and Fiskum, G. (2005). Redox mechanisms of cytoprotection by Bcl-2. Antioxid. Redox Signal. 7, 508–514.10.1089/ars.2005.7.508Search in Google Scholar PubMed PubMed Central

Krajewski, S., Tanaka, S., Takayama, S., Schibler, M.J., Fenton, W., and Reed, J.C. (1993). Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53, 4701–4714.Search in Google Scholar

Ku, B., Liang, C., Jung, J.U., and Oh, B.H. (2011). Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX. Cell Res. 21, 627–641.10.1038/cr.2010.149Search in Google Scholar PubMed PubMed Central

Li, Z.M., Jiang, W.Q., Zhu, Z.Y., Zhu, X.F., Zhou, J.M., Liu, Z.C., Yang, D.J., and Guang, Z.Z. (2008). Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin’s lymphoma cells. Cancer Biol. Ther. 7, 51–60.10.4161/cbt.7.1.5128Search in Google Scholar PubMed

Low, I.C., Loh, T., Huang, Y., Virshup, D.M., and Pervaiz, S. (2014). Ser70 phosphorylation of Bcl-2 by selective tyrosine nitration of PP2A-B56delta stabilizes its antiapoptotic activity. Blood 124, 2223–2234.10.1182/blood-2014-03-563296Search in Google Scholar PubMed

Mani, S., Rudin, C.M., Kunkel, K., Holmlund, J.T., Geary, R.S., Kindler, H.L., Dorr, F.A., and Ratain, M.J. (2002). Phase I clinical and pharmacokinetic study of protein kinase C-{alpha} antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer. Clin. Cancer Res. 8, 1042–1048.Search in Google Scholar

Mikhailov, V., Mikhailova, M., Pulkrabek, D.J., Dong, Z., Venkatachalam, M.A., and Saikumar, P. (2001). Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J. Biol. Chem. 276, 18361–18374.10.1074/jbc.M100655200Search in Google Scholar PubMed

Miyake, H., Hara, I., Yamanaka, K., Gohji, K., Arakawa, S., and Kamidono, S. (1999). Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cells. Br. J. Cancer 79, 1651–1656.10.1038/sj.bjc.6690264Search in Google Scholar PubMed PubMed Central

Moldoveanu, T., Follis, A.V., Kriwacki, R.W., and Green, D.R. (2014). Many players in BCL-2 family affairs. Trends Biochem. Sci. 39, 101–111.10.1016/j.tibs.2013.12.006Search in Google Scholar

Murphy, K.M., Ranganathan, V., Farnsworth, M.L., Kavallaris, M., and Lock, R.B. (2000). Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Differ. 7, 102–111.10.1038/sj.cdd.4400597Search in Google Scholar

Nakadate, T., Jeng, A.Y., and Blumberg, P.M. (1988). Comparison of protein kinase C functional assays to clarify mechanisms of inhibitor action. Biochem. Pharmacol. 37, 1541–1545.10.1016/0006-2952(88)90016-0Search in Google Scholar

Rao, S., Watkins, D., Cunningham, D., Dunlop, D., Johnson, P., Selby, P., Hancock, B.W., Fegan, C., Culligan, D., Schey, S., et al. (2004). Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase Cα, in patients with previously treated low-grade non-Hodgkin’s lymphoma. Ann. Oncol. 15, 1413–1418.10.1093/annonc/mdh359Search in Google Scholar

Saito, Y., Nishio, K., Ogawa, Y., Kimata, J., Kinumi, T., Yoshida, Y., Noguchi, N., and Niki, E. (2006). Turning point in apoptosis/necrosis induced by hydrogen peroxide. Free Radical Res. 40, 619–630.10.1080/10715760600632552Search in Google Scholar

Sauer, H., Wartenberg, M., and Hescheler, J. (2001). reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell. Physiol. Biochem. 11, 173–186.10.1159/000047804Search in Google Scholar

Savill, J. (1997). Recognition and phagocytosis of cells undergoing apoptosis. Brit. Med. Bull. 53, 491–508.10.1093/oxfordjournals.bmb.a011626Search in Google Scholar

Steinman, H.M. (1995). The Bcl-2 oncoprotein functions as a pro-oxidant. J. Biol. Chem. 270, 3487–3490.10.1016/S0021-9258(18)94817-9Search in Google Scholar

Tait, S.W.G. and Green, D.R. (2010). Mitochondria and cell death: outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 11, 621–632.10.1038/nrm2952Search in Google Scholar PubMed

Takano, H., Momota, Y., Kani, K., Aota, K., Yamamura, Y., Yamanoi, T., and Azuma, M. (2015). gamma-Tocotrienol prevents 5-FU-induced reactive oxygen species production in human oral keratinocytes through the stabilization of 5-FU-induced activation of Nrf2. Int. J. Oncol. 46, 1453–1460.10.3892/ijo.2015.2849Search in Google Scholar PubMed PubMed Central

Teijido, O. and Dejean, L. (2010). Upregulation of Bcl2 inhibits apoptosis-driven BAX insertion but favors BAX relocalization in mitochondria. FEBS Lett. 584, 3305–3310.10.1016/j.febslet.2010.07.002Search in Google Scholar

Tsujimoto, Y., Cossman, J., Jaffe, E., and Croce, C.M. (1985). Involvement of the bcl-2 gene in human follicular lymphoma. Science 228, 1440–1443.10.1126/science.3874430Search in Google Scholar

Ubezio, P. and Civoli, F. (1994). Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells. Free Radical Biol. Med. 16, 509–516.10.1016/0891-5849(94)90129-5Search in Google Scholar

Vela, L., Gonzalo, O., Naval, J., and Marzo, I. (2013). Direct interaction of Bax and Bak proteins with Bcl-2 homology domain 3 (BH3)-only proteins in living cells revealed by fluorescence complementation. J. Biol. Chem. 288, 4935–4946.10.1074/jbc.M112.422204Search in Google Scholar PubMed PubMed Central

Velaithan, R., Kang, J., Hirpara, J.L., Loh, T., Goh, B.C., Le Bras, M., Brenner, C., Clement, M.V., and Pervaiz, S. (2011). The small GTPase Rac1 is a novel binding partner of Bcl-2 and stabilizes its antiapoptotic activity. Blood 117, 6214–6226.10.1182/blood-2010-08-301283Search in Google Scholar PubMed

Violette, S., Poulain, L., Dussaulx, E., Pepin, D., Faussat, A.-M., Chambaz, J., Lacorte, J.-M., Staedel, C. and Lesuffleur, T. (2002). Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-XL in addition to Bax and p53 status. Int. J. Cancer 98, 498–504.10.1002/ijc.10146Search in Google Scholar PubMed

Voehringer, D.W., McConkey, D.J., McDonnell, T.J., Brisbay, S., and Meyn, R.E. (1998). Bcl-2 expression causes redistribution of glutathione to the nucleus. Proc. Nat. Acad. Sci. USA 95, 2956–2960.10.1073/pnas.95.6.2956Search in Google Scholar PubMed PubMed Central

Weinmann, M., Jendrossek, V., Handrick, R., Guner, D., Goecke, B., and Belka, C. (2004). Molecular ordering of hypoxia-induced apoptosis: critical involvement of the mitochondrial death pathway in a FADD//caspase-8 independent manner. Oncogene 23, 3757–3769.10.1038/sj.onc.1207481Search in Google Scholar PubMed

Yin, Z., Zhang, Y., Li, Y., Lv, T., Liu, J., and Wang, X. (2012). Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells. Acta Histochem. 114, 151–158.10.1016/j.acthis.2011.04.002Search in Google Scholar PubMed

Zelivianski, S., Spellman, M., Kellerman, M., Kakitelashvilli, V., Zhou, X.W., Lugo, E., Lee, M.S., Taylor, R., Davis, T.L., Hauke, R., et al. (2003). ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells. Int. J. Cancer 107, 478–485.10.1002/ijc.11413Search in Google Scholar PubMed

Zimmermann, A.K., Loucks, F.A., Schroeder, E.K., Bouchard, R.J., Tyler, K.L., and Linseman, D.A. (2007). Glutathione binding to the Bcl-2 homology-3 domain groove: a molecular basis for Bcl-2 antioxidant function at mitochondria. J. Biol. Chem. 282, 29296–29304.10.1074/jbc.M702853200Search in Google Scholar PubMed PubMed Central